Pharmacotherapeutic Potential of Natural Products in Neurological Disorders. ([2018])

• Record Type: Book
• Further Information: Note: Amritpal Singh Saroya, Jaswinder Singh.
• Authors: Amritpal Singh, 1971-; Jaswinder Singh, 1949-
• Contents: Intro; Contents; About the Authors; 1: Introduction toHerbal Medicine; 1.1 Some Basic Definitions; 1.2 History ofHerbal Medicine; 1.3 Renaissance ofHerbal Medicine; 1.4 Herbal Glossary; 2: Medicinal Herbs Used inHerbal Medicine forNeurological Disorders; 2.1 Albizia julibrissin Baker (Fabaceae); 2.2 Acorus gramineus Sol. Aiton (Acoraceae); 2.3 Acorus tatarinowii Schott (Acoraceae); 2.4 Amphilophium crucigerum (L.) L.G.Lohmann (Bignoniaceae); 2.5 Galphimia glauca Cav. (Malpighiaceae); 2.6 Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) 2.7 Litsea glaucescens Kunth (Lauraceae)2.8 Leonurus sibiricus L. (Lamiaceae); 2.9 Melissa officinalis L. (Lamiaceae); 2.10 Nepeta cataria L. (Lamiaceae); 2.11 Nepeta hindostana (Roth) Haines (Lamiaceae); 2.12 Petiveria alliacea L.; 2.13 Salvia guaranitica St. Hil. (Lamiaceae); 2.14 Sceletium tortuosum (L.) N.E.Brown (Aizoaceae); 2.15 Sorbus alnifolia (Sieb. et Zucc.) K.Koch (Rosaceae); 2.16 Stereospermum kunthianum Cham. (Bignoniaceae); 2.17 Tilia tomentosa Moench (Tiliaceae); 2.18 Verbena officinalis L. (Verbenaceae); References 3: Neuropharmacology ofGenus Hypericum: Hypericin andHyperforin3.1 Hypericum perforatum Linn. (Guttiferae); 3.2 Habitat; 3.3 Botany; 3.4 Traditional Use inTreatment ofDiseases oftheNervous System; 3.5 Chemistry; 3.5.1 Napthodianthrones; 3.5.2 Acylphloroglucinols; 3.5.3 Flavonoids; 3.5.4 Flavanols; 3.5.5 Xanthones andSterols (Mathis andOurisson 1964); 3.5.6 Terpenoids; 3.6 Neuropharmacology ofH. perforatum Extract; 3.6.1 Non-clinical Studies; 3.6.1.1 Antidepressant Activity; 3.6.1.2 Anxiolytic Activity; 3.6.1.3 Anti-dementia Activity; 3.6.1.4 Antistress Activity 3.6.1.5 Neuroprotective Activity3.7 Neuropharmacology ofHypericin; 3.7.1 Non-clinical; 3.7.2 Clinical; 3.8 Neuropharmacology ofPseudohypericin; 3.9 Neuropharmacology ofH. perforatum Xanthones; 3.10 Neuropharmacology ofH. perforatum Flavonoids; 3.11 Neuropharmacology ofHyperforin; 3.11.1 Non-clinical; 3.11.2 Clinical; 3.12 Neuropharmacology ofAdhyperforin; 3.13 Clinical Pharmacology ofH. perforatum Extract; 3.13.1 Clinical Trials inDepression; 3.13.1.1 Mild toModerate Depression; 3.13.1.2 Severe Major Depression; 3.13.2 Hypericum andSeasonal Affective Disorder (SAD) 3.13.3 Hypericum andObsessive-Compulsive Disorder (OCD)3.13.4 Comparative Trials withSynthetic Drugs; 3.13.4.1 Hypericum Extract vs Maprotiline; 3.13.4.2 Hypericum Extract Versus Imipramine; 3.13.4.3 Hypericum Extract Versus Amitriptyline; 3.13.4.4 Hypericum Extract Versus Fluoxetine; 3.13.4.5 Hypericum Extract Versus Sertraline; 3.13.4.6 Hypericum Extract Versus Citalopram; 3.13.4.7 Hypericum Extract Versus Paroxetine; 3.14 Neuropharmacology ofOther Hypericum Species; 3.14.1 Hypericum calycinum L.; 3.14.2 Hypericum caprifoliatum Cham. & Schltdl.
• Publisher Details: Singapore : Springer
• Publication Date: 2018
• Copyright Date: 2018
• Extent: 1 online resource
• Subjects: 615.78; Neuropharmacology; Natural products -- Therapeutic use; Nervous system -- Diseases -- Chemotherapy; MEDICAL / Pharmacology; Natural products -- Therapeutic use; Nervous system -- Diseases -- Chemotherapy; Neuropharmacology; Electronic books
• Languages: English
• ISBNs: 9789811302893; 9811302898
• Related ISBNs: 9789811302886
• Notes: Note: Includes bibliographical references.; Note: Online resource; title from PDF title page (EBSCO, viewed June 25, 2018).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.